Quadrant Biosciences to Offer Affordable Clarifi COVID-19 Testing to Businesses

Posted on September 15, 2021

SYRACUSE, NEW YORK, September 16, 2021 - Quadrant Biosciences Inc., a developer of molecular diagnostic tools, announced today that they will offer New York businesses with 100 or more employees affordable, weekly COVID testing to help meet new testing mandates that were announced by the federal government this week. 

The company’s Clarifi COVID-19 Test, developed in partnership with SUNY Upstate Medical University ("SUNY Upstate"), is a non-invasive, and easy to administer saliva swab test, and one of the few saliva tests to have received FDA emergency use authorization for pooled testing. Moreover, with a limit of detection (“LOD”) of as few as 600 copies of the SARS-CoV-2 virus per mL, the Clarifi COVID-19 test is the most sensitive saliva test currently on the market as referenced by the FDA.

The federal government recently announced that the Department of Labor’s Occupational Safety and Health Administration (OSHA) is developing a rule that will require all employers with 100 or more employees to ensure their workforce is fully vaccinated, or require any workers who remain unvaccinated to produce a weekly negative test result. 

To date, Quadrant’s Clarifi COVID-19 pooled testing program has been successfully adopted by numerous universities, K-12 schools, and government agencies. Recognizing that many private businesses across New York state, as well as the country, may need to quickly implement a testing program to satisfy this impending mandate, Quadrant is now offering its comprehensive and affordable testing solution to businesses. In addition to providing the test kits, the Clarifi COVID-19 testing program includes lab processing, result access via custom web app, training materials, and an account mentor to walk you through the onboarding process. 

The Clarifi COVID-19 Saliva Test is authorized for self-collection, so employers and employees can easily test on-site, with test results being delivered within 24-48 hours of samples arriving at Quadrant’s lab.  Employees, as well as designated “Organization Managers” for the company, will be able to quickly access results via an exclusive web app and make informed decisions should a positive case arise.

To learn more about COVID workplace testing, visit worksafe.quadrantbiosciences.com or request more information by completing a COVID request form

About Quadrant Biosciences

Quadrant Biosciences is a life science company developing molecular diagnostic solutions for large-scale health issues. The company has entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson's disease. Recently, it has leveraged its expertise in RNA analysis to address the Covid-19 pandemic. Quadrant participates in the Start-up NY program, a New York State economic development program. For more information about Quadrant, please visit www.quadrantbiosciences.com.

The Clarifi COVID-19 Test Kit has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meet requirements to perform high-complexity tests. Clarifi COVID-19 has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Other Member News

2025 Central New York Real Estate Conference
October 21, 2025

2025 Central New York Real Estate Conference

This one-day event offers unparalleled opportunities for networking, lead generation, and brand visibility—whether through attending, tabling, or sponsoring.

October 20, 2025

Springbrook Expands in Central New York with New Syracuse Office

The expansion marks an exciting milestone in Springbrook’s ongoing mission to provide exceptional, person-centered support across the state.

Warm, hearty meals for casual friendly get-togethers
October 17, 2025

Fulton Dining and Activity Center Menu

Reservations are encouraged and bussing is available from participants homes to the center.

Oswego Jiu Jitsu & The Mix Women's Self-Defense Seminar
October 15, 2025

Oswego Jiu Jitsu & The Mix Women's Self-Defense Seminar

Find out more information and register here.

October 15, 2025

Join SUNY Oswego for A Showcase of Innovation, Collaboration and Impact!

RSVP to join us on October 23-24, 2025 at SUNY Oswego for any or all of the following four free events.

BCBS
October 14, 2025

Excellus BCBS 2026 Enrollment

Three simple steps to finding your new plan for 2026.

Shoulder Pain? Join SOS for a Virtual Community Talk on November 12 2025
October 14, 2025

SOS to Host Virtual Community Talk: “Your Shoulder Health: Exploring Arthritis Care and Surgical Advances”

The goal of the webinar is to empower patients and caregivers with evidence-based information, demystify the treatment process, and provide a forum for questions.

John Huhtala
October 7, 2025

Tompkins Community Bank Welcomes Commercial Banking Regional Manager

Huhtala, a 28-year industry veteran known for his leadership, mentorship and community engagement, will lead operations with the goal of driving growth and value for the bank’s clients.

shake shack pic
October 7, 2025

Shake Shack Grand Opening in DeWitt

We will be donating $1 from every burger and chicken sandwich purchased to the Food Bank of Central New York.